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ABSTRACT
In Vibrio cholerae, the RNA binding protein and
chaperone Hfq (VcHfq) facilitates the pairing of the
quorum regulatory RNA (Qrr) small regulatory RNAs
(sRNAs) to the 50 untranslated regions of the mRNAs
for a number of global regulators that modulate the
expression of virulence genes. This Qrr-mediated
sRNA circuit is an attractive antimicrobial target,
but characterization at the molecular level is
required for this to be realized. Here, we investigate
the interactions between VcHfq and the Qrr sRNAs
using a variety of biochemical and biophysical tech-
niques. We show that the ring-shaped VcHfq
hexamer binds the Qrrs with 1:1 stoichiometry
through its proximal face, and the molecular
envelope of the VcHfq-Qrr complex is experimen-
tally determined from small angle scattering data
to present the first structural glimpse of a
Hfq-sRNA complex. This structure reveals that the
VcHfq protein does not change shape on complex
formation but the RNA does, suggesting
that a chaperone role for VcHfq is a critical part of
the VcHfq-Qrr interaction. Overall, these studies en-
hance our understanding of VcHfq-Qrr interactions.
INTRODUCTION
The bacterial protein Hfq regulates gene expression
by facilitating the interaction of trans-encoded small
regulatory RNAs (sRNAs) with mRNA targets to subse-
quently affect translation and/or mRNA turnover
[reviewed in (1)]. sRNAs typically base-pair with the 50
untranslated region (UTR) of an mRNA through short
regions of complementarity. sRNA binding can bring
about one of the three possible effects; ﬁrstly, and most
commonly, they can prevent translation by directly
blocking the ribosome binding site (RBS). Secondly,
they can impede or disrupt the formation of inhibitory
secondary structures in the 50 UTR to expose the RBS
and indirectly stimulate translation. Thirdly, they can
modulate the susceptibility of the mRNA to cellular ribo-
nucleases (RNases) by changing the RNA structure to
create or remove RNase cleavage sites [reviewed in (2)].
The precise role that Hfq plays in these mechanisms
remains unclear, but it includes binding of both the
sRNA and the mRNA to increase their local concentra-
tions and increase the probability of an interaction, and/or
functioning as an RNA chaperone, remodeling the struc-
ture of one, or both, of the RNAs to facilitate productive
pairing [reviewed in (1)]. Hfq could also affect the stability
of the RNA(s) by altering their structures to promote or
inhibit RNase activity (2) or by binding to canonical
RNase cleavage sites and protecting the RNA(s) (3).
sRNAs are typically expressed as part of the global stress
responses that allow bacteria to adapt their gene expres-
sion proﬁles to overcome environmental pressures such as
starvation, osmotic stress, oxidative stress and low iron
concentrations (2). For pathogenic bacteria, such as
Vibrio cholerae, Hfq-dependent sRNA-mediated gene
regulation tightly controls the expression of speciﬁc viru-
lence factors (4,5). Consequently, virulence-associated
sRNA-controlled circuits are attractive targets for the
development of novel antibacterial strategies.
In V. cholerae, four sRNAs, the quorum regulatory
RNAs 1–4 (Qrrs1–4), promote the expression of genes
required for virulence and bioﬁlm formation at low cell
density (6). The Qrrs affect the translation of at least four
mRNAs through Hfq-mediated base-pairing: hapR (6,7),
vca0939 (8), aphA (9,10) and luxOU (11). Three of these
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targets are involved in the global regulation of V. cholerae
pathogenicity: hapR encodes the HapR transcription factor
that represses virulence genes (12) and is required for the
production of hemagglutinin protease for release from
the host (13), AphA is a transcription factor that enhances
virulence-gene expression (14) and vca0939 encodes a
GGDEF protein that synthesizes the second messenger
cyclic di-guanosine monophosphate to stimulate bioﬁlm
formation (8). The four Qrrs were initially reported to be
functionally redundant, with expression of any one Qrr re-
sulting in a normal response to changing cell density (6,11).
Furthermore, inactivation of one or more Qrr(s) leads to
dosage compensation by the remaining Qrr(s) suggesting
that their combined concentration is critical for their
correct function (11). However, a recent study has shown
that, unlike Qrrs2–4, Qrr1 is unable to stimulate translation
of aphA, because it is shorter than the other Qrrs (99 nu-
cleotides compared with 111 nucleotides for Qrr2 and 110
nucleotides for Qrr3 and Qrr4) and lacks part of the region
required to base-pair with aphA mRNA (10). Qrr1 is also
predicted to adopt a different secondary structure toQrrs2–
4 [(6) and Supplementary Figure S1). Therefore, it is
possible that the Qrr sRNAs have preferential speciﬁcities
for the different mRNA targets.
Given the importance of sRNA-mediated gene regula-
tion in the pathogenicity of V. cholerae, the system is
clearly an attractive target for new antibacterial agents.
To design such a strategy and better understand how the
components interact, it is necessary to visualize the inter-
actions between Hfq, the sRNAs and the mRNAs at the
molecular level. For V. cholerae Hfq (VcHfq) and the
Qrrs, it is well-established that cognate base-pairing
between the sRNAs and the 50 UTRs of their mRNA
targets is critical for regulation and that Hfq enhances
this recognition (6–11). However, the protein-RNA inter-
actions involved are poorly understood. We have recently
shown that VcHfq binds Qrr1 tightly, with a dissociation
constant (Kd) in the low-nanomolar range (15). This
interaction is mediated primarily through the conserved
N-terminal domain of the protein, with the C-terminal
region potentially affecting the binding speciﬁcity (15).
This interaction is examined here in more detail using a
range of biochemical and biophysical techniques. VcHfq
RNA-binding mutants were prepared and used to identify
RNA-binding site(s) within the N-terminal domain of the
protein, and a novel ab initio modelling process was
developed to determine the structure of the VcHfq-Qrr1
complex from small angle scattering (SAS) data. Finally,
VcHfq-Qrr interactions were investigated for Qrrs2–4
and compared with those in the VcHfq-Qrr1 complex,
identifying their similarities and differences. Together,
these data provide insights into the molecular recognition
underlying the Qrr-mediated virulence of V. cholerae.
MATERIALS AND METHODS
Construction of Hfq expression plasmids
Construction of the pET28[VcHfq] plasmid for expression
of wild-type V. choleraeHfq has been described previously
(15). pET28[VcHfqY25D], for expression of a distal face
RNA-binding mutant, and pET28[VcHfqK56A], for ex-
pression of a proximal face RNA-binding mutant, were
generated by standard site-directed mutagenesis protocols
using pET28[VcHfq] as the template and the Y25D and
K56A mutagenic primers, respectively (Supplementary
Table S1). pET28[VcHfqY25DK56A], for expression of a
distal and proximal face RNA-binding mutant, was simi-
larly created using pET28[VcHfqY25D] as a template and
the K56A mutagenic primers (Supplementary Table S1).
Constructs were veriﬁed by DNA sequencing.
Protein expression and puriﬁcation
BL21(DE3) was transformed with either pET28[VcHfq],
pET28[VcHfqY25D], pET28[VcHfqK56A] or pET28
[VcHfqY25DK56A] and was grown in Luria broth sup-
plemented with 50 mg/ml kanamycin at 37C, until the ab-
sorbance at 600 nm reached 0.6. Expression was induced
with 1mM isopropyl b-D-1-thiogalactopyranoside, and
the cells were incubated for a further 3 hours at 37C.
Cells were harvested by centrifugation at 5000g for 20mi-
nutes at 4C, and the cell pellet was stored at 80C.
The three Hfq mutant proteins were puriﬁed in a similar
way to wild-type Hfq [described in (15)]. Cell pellets
were thawed on ice and resuspended in 20-mM Tris pH
7.4, 500-mM NaCl, 10-mM MgCl2, 1-U/ml DNase I
(Promega) and 0.5-mg/ml lysozyme (Sigma). Cells were
disrupted by sonication, and the lysate clariﬁed by centri-
fugation at 40 000g for 30minutes at 4C. After addition
of 20-mM imidazole, the supernatants were loaded onto a
HisTrap HP column (GE Healthcare) equilibrated in
20-mM Tris pH 7.4, 500-mM NaCl and 20-mM imidazole
at 4C using an A¨KTAxpress (GE Healthcare). Proteins
were eluted with a linear gradient to 1-M imidazole, and
VcHfq-containing fractions were pooled and buffer-
exchanged into 20-mM Tris pH 8, 500-mM NaCl,
2.5-mM CaCl2 and 10% glycerol using a PD10 column
(GE Healthcare). The proteins were incubated with
0.5-U thrombin (Sigma) at room temperature for 16
hours to cleave the N-terminal hexahistidine tag,
buffer-exchanged into 20-mM Tris pH 8, 1-M NaCl,
1-M (NH4)2SO4 and 0.5-mM EDTA using a PD10
column and loaded onto a HiTrap Butyl-S FF column
(GE Healthcare), equilibrated in the same buffer at 4C
using an A¨KTAxpress. Proteins were eluted with a linear
gradient to 0-M (NH4)2SO4. VcHfqY25D (the distal face
mutant) and VcHfqK56A (the proximal face mutant) were
buffer-exchanged into 20-mM 2-[4-(2-hydroxyethyl)-
piperazin-1-yl]ethanesulfonic acid (HEPES) pH 7, 100-
mM NaCl and 0.5-mM EDTA using a PD10 column
and loaded on a Mono S 4.6/100 PE column (GE
Healthcare) equilibrated in the same buffer at 4C using
an A¨KTAxpress. VcHfqY25DK56A (the distal and
proximal face double mutant) was buffer-exchanged into
20-mM 2-(N-morpholino)ethanesulfonic acid pH 6,
100-mM NaCl and 0.5-mM EDTA using a PD10
column, and loaded on a Mono S 4.6/100 PE column
equilibrated in the same buffer at 4C using an
A¨KTAxpress. All three proteins were eluted in a linear
gradient to 1-M NaCl, VcHfq-containing fractions were
buffer-exchanged into 20-mM Tris pH 8, 500-mM NaCl,
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0.5-mM EDTA and 10% glycerol using a PD10 column
and concentrated to 10mg/ml using a VivaSpin 2 cen-
trifugal concentrator, with a molecular weight cut-off
(MWCO) of 10 kDa. Concentrated proteins were loaded
onto a Superdex 200 10/300 GL size exclusion column
(GE Healthcare) equilibrated in 20-mM Tris pH 8,
500-mM NaCl, 0.5-mM EDTA and 10% glycerol using
an A¨KTApuriﬁer (GE Healthcare). VcHfq-containing
fractions were pooled, concentrated to 5mg/ml using a
VivaSpin 2 centrifugal concentrator, with a MWCO of
10 kDa and stored at 80C.
RNA synthesis
DNA templates encoding sRNAs Qrr1–4, preceded by the
T7 promoter sequence, were generated by gene synthesis
from overlapping primers (16) using the primers listed in
Supplementary Table S1. Three guanine nucleotides were
added to the 50 end of each Qrr sequence to ensure efﬁcient
transcription by T7 RNA polymerase. RNAs were then
synthesized by in vitro transcription using the
MEGAScript T7 Kit (Applied Biosystems) for unlabelled
RNA and the MAXIScript T7 Kit (Applied Biosystems)
with [a-32P]UTP (PerkinElmer) for 32P-labelled RNA.
RNA was puriﬁed using the MEGAClear Kit (Applied
Biosystems) or MicroSpin G-25 columns (GE
Healthcare) for unlabelled and 32P-labelled RNA,
respectively.
Electrophoretic mobility shift assays (EMSAs)
RNA was heated to 80C for 10minutes and was allowed
to cool to room temperature. Reactions (10-ml) were
assembled containing 5-nM 32P-labelled or 30-nM un-
labelled Qrr-RNA, the indicated concentration of VcHfq
(hexamer), 20-mM Tris pH 8, 50-mM KCl, 50-mM NaCl,
0.5-mM EDTA and 10% glycerol. Reactions were incu-
bated at room temperature for 30minutes and analysed by
6% native PAGE using TBE buffer at room temperature.
Gels with 32P-labelled RNA were visualized using a FLA-
5000 Fluoro-phosphorimager (Fujiﬁlm) and quantiﬁed
using Multi Gauge software v2.2. Kds were determined
from experiments repeated in triplicate, using a partition
function for two non-identical independent sites as
described by Lease and Woodson (17) in GraFit 5. Gels
with unlabelled RNA were stained with SYBR Gold
(Invitrogen) and visualized using a FLA-5000 Fluoro-
phosphorimager.
Mass spectrometry (MS)
Non-denaturing MS (18) was performed using 5-mM
solutions of wild-type VcHfq (hexamer) and 5-mM
Qrr1, Qrr2, Qrr3 or Qrr4 sRNA in 250-mM aqueous
ammonium acetate buffer pH 7. Samples were introduced
using nano-electrospray ionization with a TriVersa
Nanomate inlet system (Advion) and a Synapt T-wave
Ion Mobility Mass Spectrometer (IM-MS; Waters) in
positive ion mode. Experimental parameters were chosen
to preserve intact non-covalent interactions during
transfer of ions into the mass spectrometer (19). Key
settings were: backing, 8 mbar; source, 12 103 mbar;
sampling cone, 190V; extraction cone, 5V; trap and
transfer collision energy, 60 and 12V, respectively and
bias, 30V. For collision induced dissociation, trap colli-
sion energy was increased to 90V. Data were smoothed
using a window with ±50 channels using MassLynx
software, 4.0.
Surface plasmon resonance (SPR)
SPR experiments were performed at 25C using a Biacore
T100 instrument (GE Healthcare). Approximately, 1000
resonance or response units (RUs) of puriﬁed VcHfq
were immobilized onto a CM5 sensor chip (GE
Healthcare) using amine coupling. The unit RU is
deﬁned as 1 RU=1pgmm2 and is used to quantify
sensor-surface coverage. Single cycle kinetic experiments
were conducted to monitor Qrr binding with 4.7, 9.4, 18.8,
37.5 and 75-nM of each Qrr injected sequentially on the
VcHfq surface in HBS-EP (HEPES buffered saline with
EDTA and surfactant Tween 20) buffer (10-mM HEPES
pH 7.4, 150-mM NaCl, 50-mM EDTA and 0.05% Tween
20). Kds were determined using a 1:1 binding model in
T100 BiaEvaluation software v.2.0.2 (GE Healthcare).
SAS sample preparation
For both small angle X-ray scattering (SAXS) and small
angle neutron scattering (SANS), VcHfq protein and the
Qrr sRNAs were prepared in 20-mM Tris pH 8, 50-mM
NaCl, 50-mM KCl and 0.5-mM EDTA. Complexes were
prepared by mixing VcHfq protein and Qrr sRNA at
equimolar concentrations. For SANS, VcHfq-Qrr1
complex was buffer exchanged into the equivalent buffer
prepared in 0, 40, 73 or 100% D2O using a VivaSpin 2
centrifugal concentrator with a MWCO of 10 kDa.
SAXS data collection
SAXS data for the VcHfq-Qrr1 complex were collected
using standard procedures on the bioSAXS beamline
ID14-3 (20) at the European Synchrotron Radiation
Facility (ESRF, Grenoble, France) at a wavelength of
0.931 A˚ and a camera length of 2.42m. The detector was
a Pilatus1M (Dectris), and the range of momentum
transfer covered was 0.005 A˚1 < q< 0.5 A˚1. Data were
collected for VcHfq-Qrr1 at a concentration of 2mg/ml
(20-mM, assuming 1:1 stoichiometry of VcHfq
(hexamer):Qrr1 sRNA) in 10 successive 10-second
frames with the sample continuously under ﬂow. Data
were normalized to the intensity of the incident beam,
and the scattering of the buffer was subtracted in
PRIMUS (21). Data were evaluated for aggregation
(characterized by a sharp increase of the scattering curve
at low q) and radiation damage (characterized by system-
atic deviations in consecutive scattering curves). Only data
free from aggregation and radiation damage were pro-
cessed further.
SAXS data for the Qrr sRNAs and the VcHfq-Qrr2,
VcHfq-Qrr3 and VcHfq-Qrr4 complexes were collected
using standard procedures on the I22 beamline at
Diamond Light Source (DLS, Didcot, UK), equipped
with a photon counting detector (22), at a wavelength of
1 A˚ and a camera length of 3.25m. The covered range of
momentum transfer was 0.003< q< 0.55 A˚1. Data were
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collected for three concentrations, 1, 0.5 and 0.25mg/ml
(30, 15 and 7.5mM) for the Qrr sRNAs alone and 3,
1.5 and 0.75mg/ml (30, 15 and 7.5 mM, assuming 1:1
stoichiometry of VcHfq (hexamer):Qrr sRNA) for the
VcHfq-Qrr complexes, in 120 successive 1-second
frames. The data were normalized to the intensity of the
incident beam using an in-house program, and the scat-
tering of the buffer was subtracted using PRIMUS (21).
Data were evaluated for interparticle effects (characterized
by a downturn in the scattering curve at low q with
decreasing sample concentration), aggregation and
radiation damage. Only data free from aggregation and
radiation damage were processed further.
SANS data collection
SANS data were collected using standard procedures
on the D22 beamline at the Institute Laue-Langevin
(ILL, Grenoble, France) at a wavelength of 6 A˚ and
camera lengths of 2 and 11.2m. The covered range of
momentum transfer was 0.01< q< 0.3 A˚1. Data were
collected with VcHfq-Qrr1 complexes at a concentration
of 2mg/ml (20 mM, assuming 1:1 stoichiometry of
VcHfq (hexamer):Qrr1 sRNA). Data were normalized to
the intensity of the incident beam, and the scattering of the
buffer was subtracted using GRASansP v5.09 (Dewhurst,
ILL, Grenoble, France).
SAS data reduction
As the majority of information from the scattering data can
be obtained from data with q< 0.2 A˚1, all SAS data were
truncated at q=0.2 A˚1 to eliminate the noise at high q
before processing. The radius of gyration (Rg) and the
forward scattering intensity, I(0), were evaluated with the
program PRIMUS (21). Molecular masses for the SAXS
data of the Qrr sRNAs were calculated from the I(0)s,
normalized to the I(0) for phenylalanine transfer RNA.
The distance distribution functions P(r)s were generated
with the program GNOM (23) so that the Rg value agreed
with that determined from the Guinier region in PRIMUS
(21) to give the maximum particle dimension (Dmax).
Ab initio modeling of the Qrr sRNAs
Ab initio modelling of the Qrr sRNAs was performed with
DAMMIF (24). Ten independent DAMMIF runs were
carried out for each RNA. These generated similar, but
not identical, shapes in each case. An averaged ﬁltered
shape was generated using DAMAVER and DAMFILT
(25). De novo three-dimensional sRNA structures were
predicted using iFoldRNA (26,27) and were superimposed
on the ab initio models using SUPCOMB (28).
Ab initio modelling of the VcHfq-Qrr complexes
Ab initio modelling of the VcHfq-Qrr1 and VcHfq-Qrr2
complexes was performed using the multiphase dummy-
atom modelling program MONSA (29,30). Default
settings were used, with the exception that the looseness
penalty was changed to 200 for VcHfq-Qrr2 modelling.
The protein phase, from SAXS data of the protein
alone, was modelled as described previously (15). The
model was moved to the origin with MASSHA (31) and
a spherical search volume of either 155 A˚ or 200 A˚ diam-
eters was created using the auxiliary ATSAS program
pdb2dam4 (available upon request from ATSAS devel-
opers) for the VcHfq-Qrr1 and VcHfq-Qrr2 complexes,
respectively. The diameters were chosen on the basis of
a value slightly larger than that of the Dmax values
determined from the P(r) functions, so as to minimize
any constraint on the RNA structure during the modelling
process. The following edits were made to the pdb outputs
to maintain the Hfq phase during MONSA runs: ‘Hspace’
was replaced with ‘CA’, ‘0 1 201’ was replaced with ‘0 1
202’ and ‘0 2 201’ was replaced with ‘1 2 201’. These ﬁles
were used as the starting search volume in MONSA and
effectively ‘ﬁxed’ the protein phase of the complex.
Two datasets were used during the modelling process to
determine the structure of the RNA in the VcHfq-Qrr1
complex: SAXS data and 0% D2O SANS data. Only
SAXS data were used for modelling the VcHfq-Qrr2
complex. Theoretical volumes for the individual phases,
based on the amino acid for the protein and the nucleotide
sequence for the RNA, and Rg values for the individual
phases and the complex as a whole, determined from
Guinier analysis, were used as constraints during the
modelling process. The program MULCh (ModULes for
the analysis of Contrast variation data) (32) was used to
calculate the theoretical values of the scattering length
density and scattering length difference (contrast), based
on the amino acid sequence for the protein, the nucleotide
sequence for the RNA and buffer composition. No
symmetry constraints were imposed. The ﬁts to the experi-
mental data for the VcHfq-Qrr1 complex had 2 values of
1.39 and 0.34 for the SAXS and SANS data, respectively,
and the ﬁt to the experimental data for the VcHfq-Qrr2
complex had a  value of 0.19.
Circular dichroism (CD)
CD data were collected on an applied photophysics p*-180
spectrometer, using a cuvette with a 0.4-mm path length.
Three experiments were conducted after Qrr sRNAs were
prepared at 0.5–2mM in 10-mM Tris pH 8 and 100-mM
NaCl, heated to 80C for 10minutes and allowed to cool
back to room temperature. Firstly, data for the Qrr sRNAs
alone were collected at wavelengths spanning 200–360 nm
in 1-nm steps at 20C. Secondly, spectra for each Qrr
sRNA were collected at temperatures from 20C to 92C,
with 4C increments. Finally, the spectra were collected for
each Qrr sRNA as they were titrated with VcHfq to a ratio
of 1:2 Qrr:VcHfq. Data from four or six scans were
averaged, baseline-subtracted, smoothed using the
Savitsky–Golay routine and calibrated against camphor
sulphonic acid. Where appropriate, the protein contribu-
tion was also subtracted. Spectra were converted into
molar ellipticity units (deg1 cm2 dmol1).
RESULTS
VcHfq binds Qrr sRNAs with 1:1 stoichiometry
Escherichia coli Hfq is known to bind sRNAs with Kds,
typically in the low-nanomolar range (33,34). In EMSAs,
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on addition of VcHfq to Qrr1, a distinct VcHfq-Qrr1
complex is formed and further addition of VcHfq leads
to the formation of a higher order, less well-deﬁned
complex or complexes [(15) and Figure 1a]. Assuming
that VcHfq is hexameric, the fraction of bound Qrr1 at
each concentration of VcHfq was ﬁt to a partition
function for the protein bound to two independent sites
on Qrr1 to give a Kd of 25 nM for the ﬁrst complex
formed [(15) and Figure 1a].
To determine the likely stoichiometry of the VcHfq-
Qrr1 complex(es), mixtures of VcHfq and Qrr1 sRNA
were analysed using non-denaturing MS [Figure 1b;
(18)], a technique that can be used to study non-covalent
complexes. Experimental parameters were selected to
preserve intact non-covalent interactions in the mass spec-
trometer (19). Protein-RNA complexes are expected to
give rise to a series of peaks in the mass (m)/charge (z)
spectrum that will be related by a common mass. This
mass is the mass of the complex and allows determination
of the stoichiometry of the complex, assuming that the
complex constituents are known. Initially, VcHfq and
Qrr1 were mixed at equimolar concentrations, assuming
that VcHfq is present as a hexamer, and at a concentration
above the Kd for the discrete complex observed in the
EMSAs. A peak series corresponding to the 14–17+
charge states of a species with a mass of 92 670 Da were
observed (Figure 1b). This species is consistent with a 1:1
VcHfq:Qrr1 complex, which has a theoretical mass of 92
860.4 Da. When VcHfq and Qrr1 were mixed with VcHfq
in excess, again at concentrations above the Kd
determined from the EMSAs, only a peak series corres-
ponding to a 1:1 complex could be clearly detected. From
these data we concluded that hexameric VcHfq only forms
stable complexes with Qrr1 with 1:1 stoichiometry and
propose that the discrete band observed in the EMSAs
is a 1:1 VcHfq:Qrr1 complex.
Qrr1 is only one of four, functionally redundant, Qrr
sRNAs present in V. cholerae (6), and the ability of VcHfq
to form complexes with Qrr2, Qrr3 and Qrr4 was also
examined by EMSAs (Supplementary Figure S2) and
non-denaturing MS (Supplementary Figure S3). As can
be seen from the left-most panels in Supplementary
Figure S2, addition of VcHfq to each Qrr sRNA results
in the formation of a discrete complex with poorly deﬁned
higher order complexes visible on continued addition of
proteins. Non-denaturing MS of equimolar mixtures of
VcHfq (hexameric) with Qrr2, Qrr3 or Qrr4, at concentra-
tions above the Kd of the deﬁned VcHfq:Qrr complexes
observed in the EMSAs, produced peak series correspond-
ing to complexes with 1:1 stoichiometry only (Sup-
plementary Figure S3). Again this suggests that the
stable species observed in the EMSAs is a 1:1 complex
and that hexamericVcHfq binds to each Qrr with 1:1
stoichiometry.
VcHfq-Qrr complexes are of comparable stability
To investigate whether there might be subtle differences
between the complexes formed between VcHfq and each
of the four Qrrs, the binding afﬁnity of each Qrr for
VcHfq was measured by SPR. Single cycle kinetic experi-
ments were performed in which VcHfq protein was
immobilized to the sensor surface, and Qrr sRNA was
injected at increasing concentrations in a single cycle
without regenerating the surface between injections. The
Qrr sRNA concentration range was selected such that,
based on the EMSAs (Supplementary Figure S2), only
1:1 VcHfq (hexamer):Qrr complexes would be formed,
allowing data to be ﬁt to a 1:1 binding model.
Sensorgrams of Qrr1, Qrr2, Qrr3 and Qrr4 binding to
VcHfq are shown in Figure 2, together with the ﬁts to
the data and the calculated Kds. From these data, it is
clear that all four Qrrs bind VcHfq tightly, with similar
low-nanomolar Kds.
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Figure 1. VcHfq binds Qrr1 with 1:1 stoichiometry. (a) EMSA with
VcHfq and 32P-labelled Qrr1 sRNA. Qrr1 was present at 5 nM in
each lane and the concentration of hexameric VcHfq protein is
indicated above the lane. The mobilities of free Qrr1 RNA, the 1:1
VcHfq:Qrr1 complex and higher order complexes are indicated on
the right of the gel. The dissociation constant (Kd) for the 1:1
VcHfq:Qrr1 complex is reported above the gel and was calculated
from three repeats. (b) Non-denaturing MS spectrum of VcHfq and
Qrr1 sRNA. VcHfq and Qrr1 were mixed at equimolar concentrations.
A peak series corresponding to the 14–17+ charges states of the 1:1
VcHfq (hexamer):Qrr1 complex is labelled with C (theoretical mass: 92
860.4 Da; experimental mass: 92 670 Da). A smaller series of peaks,
centred on the 8+ charge state, corresponds to a small amount of
monomeric VcHfq and is labelled with M (theoretical mass 10 163.6
Da; experimental mass: 10 166.9 Da).
Nucleic Acids Research, 2012 5
 at U
niversity of Portsm
outh Library on Septem
ber 26, 2012
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
The relative stability of the 1:1 VcHfq (hexamer):Qrr
complexes was also assessed by MS CID experiments.
MS parameters were initially selected to observe intact
1:1 VcHfq (hexamer):Qrr complexes and then the trap
collision energy was gradually increased to cause the
complexes to dissociate. For each VcHfq-Qrr complex,
the disappearance of the complex and the appearance of
free VcHfq (monomer) were monitored. At a trap collision
energy of 60V, essentially all of the VcHfq were present as
an intact 1:1 complex, with the Qrr sRNA for all four Qrrs
(Figure 1b and Supplementary Figure S3). In contrast, at
a trap collision energy of 90V, a signiﬁcant amount of free
VcHfq (monomer) could be detected in each case
(Supplementary Figure S4). Based on the relative heights
of the VcHfq (monomer) and the VcHfq-Qrr complex
peaks, slightly more VcHfq had dissociated for the Qrr1
and Qrr3 complexes than for the Qrr2 and Qrr4 complexes
at 90V. Small amounts of free VcHfq were also detected
with the VcHfq-Qrr1 and VcHfq-Qrr3 complexes but not
for the VcHfq-Qrr2 or VcHfq-Qrr4 complexes at the
starting trap collision energy (Figure 1b and
Supplementary Figure S3). This suggests that there may
be subtle differences in the stability of each VcHfq-Qrr
complex, dependent on the Qrr sRNA involved.
Qrr sRNAs bind to the proximal face of VcHfq
The conserved N-terminal domain of the Hfq protomer
adopts the Sm fold of an N-terminal a-helix followed
by ﬁve b-strands (35–40). Six of these monomers form a
ring from which the disordered C-terminal regions
extend outward to give an overall star-shaped structure
(15,35–41). There are two principal RNA-binding sites
on Hfq that have been well characterized through
both structural (39) and mutagenesis studies (42): the prox-
imal face and the distal face. The proximal face is the side
with the exposed a-helices and C-terminal region and it
preferentially binds single-stranded AU-rich RNA, which
includes most sRNAs and their mRNA targets (37,40,42).
Six consecutive nucleotides can bind to this face in a
circular conformation around the central pore of the
protein (37,38,40), and an additional uracil recognition
site is located near to the N-terminus of the a-helix of
each monomeric subunit (40). In contrast, the distal face is
speciﬁc for poly(A) or A-R-N (where R is a purine and N
is any nucleotide) triplets, both of which are often found
in mRNAs (36,37,40,42). Again the binding topology is
circular. However, the six binding pockets can each ac-
commodate three nucleotides to bind up to a total of 18
nucleotides (36). The key residues involved in RNA
binding for E. coli Hfq have been identiﬁed for each
face and include Lys56 on the proximal face and Tyr25
on the distal face. Mutation of Lys56 to Ala and Tyr25 to
Asp impairs proximal and distal face binding, respectively
(42). As both of these amino acids are conserved in
VcHfq, we tested whether mutating them would similarly
impair the RNA-binding ability of the V. cholerae protein.
To investigate which face of VcHfq the Qrr sRNAs bind
to, mutations were introduced on the distal face (Y25D),
the proximal face (K56A) and both faces (Y25D K56A) of
VcHfq. Their ability to bind to the Qrr sRNAs was then
compared using EMSAs. Figure 3 shows gels from repre-
sentative EMSAs for the three mutant VcHfq proteins
binding to Qrr1. The distal face mutant binds Qrr1 with
an afﬁnity that is similar to, or perhaps slightly higher
than, the wild-type protein (compare the top panel of
Figure 3 with Figure 1a), suggesting that the distal face
of VcHfq does not play a major role in Qrr1 binding.
However, the proximal face mutant binds Qrr1 compara-
tively weakly (Kd 345±130 nM) and the double mutant
was essentially unable to detectably bind Qrr1 at the con-
centrations tested. This implies that VcHfq preferentially
binds Qrr1 with its proximal face, although interactions
are possible with the distal face. These results indicate that
the RNA-binding modes employed by VcHfq, through the
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Figure 2. VcHfq binds to all four Qrr sRNAs with low-nanomolar afﬁnity. SPR sensorgrams for Qrr1, Qrr2, Qrr3 and Qrr4 binding to immobilized
VcHfq. Experimental data is represented by a red line and the ﬁt to a 1:1 binding model by a black line in each case. The calculated dissociation
constant (Kd) is reported in the top left-hand corner of the sensorgram.
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distal and proximal faces, are similar to those in E. coli
Hfq.
Similar EMSAs were also carried out for Qrr2, Qrr3
and Qrr4, and representative gels are shown in
Supplementary Figure S2. As for Qrr1, the distal face
mutant of VcHfq is able to bind each Qrr with an
afﬁnity similar to wild-type, whereas the proximal face
mutant binds more poorly. However, the effect of the
proximal site mutation is not as pronounced for Qrrs2–
4, as it is for Qrr1 suggesting that the preference for
binding through the proximal face is not as strong for
Qrrs2–4. Finally, the double mutant was unable to bind
any of the Qrrs in the concentration range tested, conﬁrm-
ing that RNA-binding interactions are mediated through
the distal and/or proximal face of VcHfq.
Low-resolution solution structure of the VcHfq-Qrr1
complex
To investigate the organization of the VcHfq-Qrr1
complex, SAXS and SANS experiments were performed.
VcHfq has been examined by SAXS previously and
revealed that VcHfq hexamer adopts a six-pointed
star-shaped conformation with six-fold symmetry (15).
Here, Qrr1 sRNA, both free and in complex with
VcHfq, has been examined by SAXS. The VcHfq-Qrr1
complex was prepared at a concentration where the stoi-
chiometry would be expected to be 1:1 VcHfq
(hexamer):Qrr1 based on the MS data (Figure 1b). The
1:1 VcHfq-Qrr1 complex was also examined in 0, 40, 73
and 100% D2O by SANS. SANS uniquely allows the
spatial location of a single component of a protein–
RNA complex, either the protein or the RNA, to be
determined using contrast variation in a range of H2O/
D2O mixtures to match out one of the components. In 0
and 100% D2O, scattering should be from the entire
complex, whereas at 40 and 73% D2O scattering should
be predominantly from the Qrr1 sRNA or the VcHfq
protein component, respectively. When combined, these
experiments, allowed the overall structure of the
complex to be determined along with the conformations
of the individual components in both their free forms and
bound forms.
The parameters determined from the SAXS and SANS
data are shown in Table 1. The Rg and Dmax values for the
VcHfq-Qrr1 complex are 41 A˚ and 135–145 A˚, respect-
ively. These values are higher than for either the VcHfq
protein component [Rg, 31.5 A˚; Dmax, 103 A˚ (15)] or the
Qrr1 sRNA component (Rg, 34.0 A˚; Dmax, 130 A˚) alone
and would be consistent with VcHfq binding to a region of
the RNA with unbound nucleotides extending away from
the protein.
MONSA (29,30) was selected for ab initio modelling of
the VcHfq-Qrr1 complex. This program attempts to
minimize the discrepancy between the ﬁt of the model
and the experimental data and describes the model as an
assembly of beads within a spherical search volume.
A caveat of this approach is that it is not possible to
impose phase-speciﬁc symmetry during the modelling
process, a signiﬁcant disadvantage given the expected
six-fold symmetry of the VcHfq protein.
It was possible to overcome this difﬁculty because the
protein does not seem to signiﬁcantly change shape on
complex formation. SAXS data of the free protein was
compared with the SANS data of the VcHfq-Qrr1
complex in 73% D2O. This is the percentage of D2O at
which the RNA phase of the complex is matched out and
only scattering from the protein phase is observed. The
parameters extracted from these data sets are similar
(Table 1). Rgs were 31.5 A˚ and 31.7 A˚ and Dmaxs were
103 A˚ and 105 A˚ for the free VcHfq protein and VcHfq
in complex with Qrr1 sRNA, respectively. Also, the
proﬁles of the two scattering curves, shown in Figure 4,
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Figure 3. VcHfq preferentially binds Qrr1 with its proximal face.
Representative EMSAs for a distal face mutant (Y25D), a proximal
face mutant (K56A) and a distal and proximal face double mutant
(Y25D K56A) of VcHfq binding to Qrr1 sRNA. Qrr1 was labelled
with 32P and was present at 5 nM in each lane and the concentration
of hexameric VcHfq protein is speciﬁed above the lane. The mobilities
of free Qrr1 RNA, the 1:1 VcHfq:Qrr1 complex and higher order
complexes are indicated on the right of the gels. The dissociation
constant (Kd) for the 1:1 VcHfq:Qrr1 complex, calculated from three
repeats, is reported above each gel.
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are almost identical. Together these data suggest that the
protein adopts the same conformation in both its free
form and in complex with Qrr1.
Given that the overall shape of the protein does not
change on complex formation, it was decided that the
model generated from the SAXS data of the free VcHfq
protein (15) should be used as the input for MONSA to
effectively ‘lock’ the symmetry and position of the protein
in the model (see Materials and Methods for further
details). The SAXS data of the VcHfq-Qrr1 complex
and the SANS data of the complex in 0% D2O were
then used for modelling. Scattering curves and distance
distribution functions (P(r)s) for these data sets are
shown in Figures 5a and b, respectively. The SANS
data for the complex in 100% D2O was similar to that
in 0% D2O and was excluded from the modelling based
on redundancy. The SANS data for the VcHfq-Qrr1
complex in 40% D2O was also not included in the
modelling process because of the poor signal-to-noise
ratio in this dataset. The resultant ab initio model of the
VcHfq-Qrr1 complex is presented in Figure 5c, and it
clearly shows that VcHfq binds the Qrr1 sRNA across a
single face. From the mutagenesis studies discussed previ-
ously, this is most likely the proximal face.
VcHfq alters the structure of Qrr1 sRNA
Escherichia coli Hfq has been reported to be an RNA
chaperone, changing the structure of RNAs on binding
(43). To investigate whether VcHfq alters the structure
of Qrr1 sRNA, a similar approach was taken to that
used to prove that the protein adopts the same conform-
ation when free and when in complex with Qrr1. SAXS
data of the free Qrr1 sRNA was compared with the SANS
data of the VcHfq-Qrr1 complex in 40% D2O, the per-
centage of D2O at which the protein phase of the complex
is matched out and only scattering from the RNA phase is
observed. Because of the poor signal-to-noise ratio in the
SANS data, it is difﬁcult to tell if the parameters extracted
from the data (Table 1) or the proﬁles of the scattering
curves for these datasets, shown in Figure 6a, really do
differ.
To further investigate potential VcHfq-induced con-
formational changes of Qrr1, the sRNA was examined
by CD (Figure 6b). As VcHfq was titrated into
Qrr1, the molar ellipticity at 265 nm decreased gradually
up to a VcHfq:Qrr1 ratio of 1:1. To explore the extent
of Qrr1 unfolding that this represented, heating experi-
ments were conducted on the sRNA alone. As tempera-
ture was increased from 20C to 92C, a much larger
change in ellipticity was observed relative to the addition
of VcHfq. The position of the peak maxima also
changed from 265 nm to 272 nm, consistent with the
RNA transitioning toward a more single-stranded charac-
ter. Therefore, the remodelling effect of VcHfq was
equivalent to heating Qrr1 to 44C, suggesting that
VcHfq binding causes partial unwinding or restructuring
of the RNA.
Ab initio models were generated for free Qrr1 sRNA
and were in reasonable agreement with the three-
dimensional structure predicted using iFoldRNA (26,27),
as can be seen from the superposition of the predicted
structure onto the average of the models in Figure 6c.
This predicted structure could not be superimposed onto
the ab initio model of Qrr1 in complex with VcHfq
(Figures 5c and 6c) implying that the RNA has changed
shape following VcHfq binding. Together, these data
indicate that VcHfq does act as an RNA chaperone with
respect to Qrr1 sRNA.
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Figure 4. The conformation of VcHfq does not change on complex
formation. SAXS scattering curve of free VcHfq (circles) and SANS
scattering curve of the VcHfq-Qrr1 complex in 73% D2O (triangles).
SAS proﬁles have been normalized to the same intensity.
Table 1. SAXS and SANS parameters
D2O (%) Rg (A˚) Dmax (A˚)
SAXS
VcHfqa 0 31.5±0.112 103
Qrr1 0 34.0±1.20 130
Qrr2 0 41.1±2.05 164
Qrr3 0 46.3±2.95 175
Qrr4 0 41.1±2.20 160
VcHfq-Qrr1 0 41.5±2.04 145
VcHfq-Qrr2 0 52.3±1.65 200
VcHfq-Qrr3 0 52.7±3.85 178
VcHfq-Qrr4 0 50.4±2.70 200
SANS
VcHfq-Qrr1 0 41.0±0.898 135
VcHfq-Qrr1 100 40.9±0.349 135
VcHfq in situ 73 31.7±1.59 105
Qrr1 in situ 40 41.2±4.95 NDb
aData from Vincent et al. (15) shown for comparison.
bNot determined.
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Comparison of the VcHfq-Qrr complexes
SAXS data were also collected for Qrr2, Qrr3 and Qrr4 in
their free forms and in complex with VcHfq. The VcHfq-
Qrr complexes were again prepared at a concentration
where the stoichiometry would be expected to be
1:1 VcHfq (hexamer):Qrr based on the MS data
(Supplementary Figure S3). The parameters that were
extracted from these data are shown in Table 1. The Rg
and Dmax values determined for Qrrs2–4 in their free form
and in complex with VcHfq, are larger compared with
Qrr1. This most likely reﬂects the differences in the
lengths and structures of the RNAs, with Qrr1 containing
99 nucleotides, Qrr2 111 nucleotides and Qrrs3 and 4 110
nucleotides (Supplementary Figure S1). The scattering
curves for the VcHfq-Qrr complexes, with that for
VcHfq-Qrr1 shown again for comparison, are presented
in Supplementary Figure S5a. The proﬁles of the scatter-
ing curves for the VcHfq-Qrr complexes for Qrr2–4 are
similar, but they differ to that for VcHfq-Qrr1. Likewise,
the P(r) functions in Supplementary Figure S5b are similar
for Qrr2–4 in complex with VcHfq but different for
VcHfq-Qrr1. This suggests that the VcHfq-Qrr complexes
for Qrr2–4 will adopt a similar conformation but one that
is different to that of VcHfq-Qrr1.
SANS data were not collected for Qrr2–4 in complex
with VcHfq. However, modelling of the VcHfq-Qrr2
complex, as an example of the VcHfq-Qrr complexes for
Qrr2–4, was performed with MONSA (29,30) by starting
with the assumption that the VcHfq protein does not
change shape on complex formation with any of the
Qrrs. It was then possible to use the SAXS model of the
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Figure 5. Low-resolution model of the VcHfq-Qrr1 complex. (a) SAXS scattering curve for free VcHfq (squares), SAXS scattering curve for the
VcHfq-Qrr1 complex (circles) and SANS scattering curve for the VcHfq-Qrr1 complex in 0% D2O (triangles). Back-transformed distance distribution
functions, P(r), are shown as a solid grey line, a solid dark orange line and a solid light orange line for the SAXS data of free VcHfq, the SAXS data
of the VcHfq-Qrr1 complex and the SANS data of the VcHfq-Qrr1 complex, respectively. (b) P(r) functions for the SAXS data of free VcHfq (grey),
the SAXS data of the VcHfq-Qrr1 complex (dark orange) and the SANS data of the VcHfq-Qrr1 complex (light orange). (c) Ab initio model of the
VcHfq-Qrr1 complex generated in MONSA (29,30) and visualized in PyMOL. VcHfq is shown as grey spheres and the Qrr1 sRNA as dark orange
spheres.
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free VcHfq as an input for MONSA, just as for
VcHfq-Qrr1. The complex was then modelled using the
SAXS data for the VcHfq-Qrr2 complex. The ﬁnal
ab initio model is shown in Supplementary Figure S5c.
Similar to VcHfq-Qrr1, Qrr2 sRNA binds predominantly
to one face of VcHfq and, from the mutagenesis studies,
this is most likely the proximal face. However, more of the
RNA seems to be exposed to the solvent in the
VcHfq-Qrr2 complex, probably because of the longer
length of the sRNA and VcHfq only being able to bind
a ﬁnite number of nucleotides.
To investigate whether the structure of Qrr2 changes on
VcHfq binding, CD and ab initio modelling were
employed. The CD spectra shown in Supplementary
Figure S6a show that the molar ellipticity of Qrr2 at
265 nm is lower in the presence of VcHfq, and that this
decrease is equivalent to heating the sRNA to 44C. This
implies that VcHfq does partially unwind Qrr2 on
binding. Similarly, ab initio modelling showed small
changes in the conformation of Qrr2 in complex relative
to the free form, such that the predicted structure of Qrr2
generated in iFoldRNA (26,27) could be superimposed on
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Figure 6. The conformation of the RNA changes on complex formation. (a) SAXS scattering curve of free Qrr1 (circles) and SANS scattering curve
of the VcHfq-Qrr1 complex in 40% D2O (triangles). SAS proﬁles have been normalized to the same intensity. (b) CD spectra for VcHfq-Qrr1
complexes (orange lines) at 20C at VcHfq:Qrr1 ratios of 0:1 (solid orange line) and 1:1 (dotted orange line) and for free Qrr1 sRNA (black lines) at
20C (solid black line), 44C (dotted black line) and 92C (dashed black line). Qrr1 was present at 0.7 mM in each case. (c) The upper panels show a
ribbon representation of Qrr1, predicted by iFoldRNA (26,27), superimposed with SUPCOMB (28) on the ab initio model of the sRNA (spheres)
generated from the SAXS data of free Qrr1 with DAMMIF (24) and averaged with DAMAVER and DAMFILT (25). The lower panels show the ab
initio model of the sRNA, as it appears in complex with VcHfq, generated from the SAXS and SANS data of the complex with MONSA (29,30). All
models were visualized with PyMOL.
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the model of the free Qrr2 with reasonable agreement, but
not on the model of Qrr2 in complex with VcHfq
(Supplementary Figure S6a).
Finally, the VcHfq-Qrr3 and VcHfq-Qrr4 complexes
were also investigated by CD. The spectra are shown in
Supplementary Figures S6b and S6c, respectively, and
reveal that the molar ellipticity of these RNAs also de-
creases in the presence of VcHfq. For Qrr3, the VcHfq
binding was equivalent to heating the RNA to 44C, but
heating to only 36C could produce the same effect for
Qrr4. This data suggest that VcHfq acts as an RNA chap-
erone with all four Qrr sRNAs, but the requirement for
VcHfq may be slightly lower for Qrr4.
DISCUSSION
The RNA binding sites on Hfq have been well-deﬁned, but
the stoichiometry of Hfq-RNA complexes has been a con-
troversial topic. The toroidal hexameric Hfq protein
presents two binding faces (proximal and distal),
each with six nucleotide-binding pockets (36,37,39,40).
Consequently, each Hfq hexamer has the capability to
bind multiple RNAs and, similarly, any given RNA can
have multiple Hfq-binding sites. The situation is further
complicated by the recent report that Hfq is not always
hexameric (44). Panja and Woodson demonstrate that
at monomer concentrations in the nM range, low-
micromolar range and low-to-mid micromolar range
E. coli Hfq is monomeric, hexameric or multimeric,
respectively (44). Our non-denaturing MS analyses,
performed at a VcHfq (monomer) concentration in the
mid micromolar range, detected VcHfq-Qrr complexes
with 1:1 VcHfq (hexamer):Qrr sRNA stoichiometry.
Although VcHfq may have been expected to be multimeric
under these conditions (44), it has been reported that
multimer formation is disfavoured in the presence of
RNA (17,45). The EMSA data are perhaps more difﬁcult
to interpret with respect to complex stoichiometry. These
experiments were performed with a concentration of
VcHfq (monomer) in the mid to high nanomolar range
when the protein might be expected to be transitioning
from a monomer-hexamer equilibrium to a hexamer
(44). Nevertheless, we conclude that the discrete
complexes observed in the gels do represent 1:1 VcHfq
(hexamer):Qrr sRNA complexes, as hexameric VcHfq
would be expected to be the predominant species present
under our experimental conditions and a higher stoichi-
ometry would be inconsistent with the MS results.
Therefore, we suggest that hexameric VcHfq binds to
each of the Qrr sRNAs with 1:1 stoichiometry. Previous
studies have suggested that the C-terminal region of the
protein is important for maintaining the speciﬁcity of
binding and hence, the stoichiometry of Hfq:sRNA
complexes (15).
Kds determined by SPR and the stability of each of the
VcHfq-Qrr complexes assessed by collision induced MS
were comparable. Only subtle differences between the dif-
ferent complexes could be detected, with the VcHfq-Qrr3
complex potentially being the least stable (Supplementary
Figure S4). This suggests that the VcHfq-Qrr interaction is
similar for each Qrr and is unlikely to account for the
different mRNA target speciﬁcity reported for Qrr1 (10).
The minor stability differences most likely reﬂect slight
differences in the VcHfq binding site on each sRNA.
Hfq has been shown to bind to the poly(U) tails formed
by the Rho-independent transcriptional terminators (37)
and VcHfq could potentially bind to the 30 poly(U) tail of
the Qrrs. Interestingly, the poly(U) tail is shortest for Qrr3
(Supplementary Figure S1) which could explain the lower
stability for the VcHfq-Qrr3 complex.
Most sRNAs preferentially bind to the proximal face of
Hfq (33,42), and this also seems to be the case for the Qrrs
binding to VcHfq. The proximal face mutant has a
far greater impact on sRNA binding than the distal face
mutant for Qrr1. The ﬁndings that the distal face mutant
can potentially bind Qrr1 more tightly than the wild-type
protein and that both mutations on the distal and
proximal face are required to prevent RNA binding indi-
cates that Qrr1 can bind to both faces of VcHfq. It is
possible that the 1:1 complex formed with the wild-type
protein is actually a mixture of complexes with the sRNA
bound to either the proximal or the distal face of VcHfq,
but with Qrr1 bound predominantly to the proximal face.
It has been reported that the K56A (proximal face)
mutation, but not the Y25D (distal face) mutation, desta-
bilizes the E. coli hexamer and this instability could impair
the Hfq-RNA interaction (44). Although both the Y25D
and K56A VcHfq mutants were hexameric based on size
exclusion chromatography (data not shown), we cannot
exclude the possibility that the differential effects of the
distal and proximal face mutants arise partly from
the proximal face mutation affecting the stability of the
hexamer.
Similarly, binding to Qrrs2–4 was affected more by the
proximal face mutant than the distal face mutant.
However, the preference for forming the 1:1 complex
with the sRNA binding to the proximal face is not so
pronounced. Although there are no signiﬁcant poly(A)
stretches or ARN repeats in any of the four sRNAs to
mediate distal-face binding, each Qrr does contain at
least one ARN triplet. Based on secondary structure pre-
dictions [(6) and Supplementary Figure S1], these ARN
triplets would be in a single-stranded region of the RNA
and, therefore, accessible to VcHfq. Potentially, multiple
ARN triplets could come together in the tertiary structure
of the RNAs to strengthen the binding to the distal face,
especially in the case of Qrrs2–4.
The low-resolution models of the VcHfq-Qrr1 and
VcHfq-Qrr2 complexes are the ﬁrst structures that show
a full-length Hfq protein binding to a full-length sRNA.
These structures support the mutagenesis studies that the
Qrrs bind predominantly to one face of the VcHfq protein
(presumably the proximal face). A number of crystal
structures of Hfq bound to short oligoribonucleotides
have revealed that Hfq can bind six consecutive nucleo-
tides in a circular conﬁguration around the central pore
formed by the protein’s N-terminal core (36–38,40).
Consistent with these structures, Figure 5c and
Supplementary Figure S5c show that signiﬁcant inter-
actions occur between the VcHfq core and the sRNAs.
However, there is little evidence that either Qrr1 or Qrr2
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adopt the circular conﬁguration observed for short
oligoribonucleotides (36–38,40). This suggests that only
a subset of the nucleotide-binding sites are actually
occupied by the sRNA. Potentially, the tertiary structure
of the longer sRNA prevents binding to all six
nucleotide-binding sites simultaneously. The models of
the VcHfq-Qrr1 and VcHfq-Qrr2 are most similar to the
recent structure reported for E. coli Hfq bound to an
eight-nucleotide fragment of DsrA (40). In this structure,
seven nucleotides were bound on the proximal face, four
nucleotides had the expected circular conformation, two
nucleotides ﬂoated above the central pore and a single
uracil was located near the N-terminus of the a-helix,
distant from the central pore. Recent studies have sug-
gested that sRNA-mRNA pairing is facilitated when the
regions required for pairing are bound to the same face of
Hfq (34,46). Secondary interactions between distant
regions of the mRNA and the opposite face of VcHfq
may help to stabilize the ternary complex. The models
of the VcHfq-Qrr complexes could clearly accommodate
an mRNA on the same face as the bound sRNA and/or on
the opposite face.
In addition to the contacts between the VcHfq core
and the Qrrs, the models also suggest that the
C-terminal region of VcHfq could be involved in RNA
binding. Investigations into the function of the disordered
C-terminal region of Hfq proteins have suggested a role in
RNA binding, with the C-terminus being required to
maintain binding speciﬁcity and stoichiometry (15). It
has been proposed that the C-terminus is able to make
long-range interactions and possibly becomes more
structured on RNA binding to stabilize the complex
(41). However, the solution scattering studies described
here revealed that the VcHfq protein does not signiﬁcantly
change conformation on complex formation with Qrr1.
Therefore, any structural changes to the C-terminal
region to facilitate RNA binding must be transient, such
that the protein structure is essentially unchanged in the
stable VcHfq-Qrr1 complex.
In addition to binding RNA, Hfq can function as a
chaperone, altering the structure of the RNA (43,47). In
contrast to the protein, the structure of each of the Qrr
sRNAs does seem to change on Hfq-binding. Changes in
Qrr structure, observed by CD and SAS, are consistent
with a loss of double-stranded character in the RNA
and it implies that Hfq has chaperone activity with the
Qrrs. The temperature required to cause the same effect
as VcHfq-binding is slightly lower for Qrr4 than for the
other three Qrrs, but it is not clear why less structural
rearrangement is possible or required for this sRNA.
The requirement for Hfq-mediated unwinding could
explain how Hfq enhances sRNA-mRNA pairing in this
V. cholerae system.
Where exactly the VcHfq protein binds on the sRNAs,
and the nature of the structural changes that it produces
remain to be determined. Likewise, understanding the
interactions between VcHfq and the mRNA targets of
the Qrrs is important. Most likely, a ternary complex,
consisting of VcHfq, a Qrr sRNA and an mRNA target,
is formed for VcHfq to facilitate Qrr-mRNA pairing.
What form this ternary complex will take is an intriguing
question awaiting structural studies. Will the mRNA bind
next to the sRNA on the proximal face or bind on the
opposite, distal face? Will structural rearrangements of the
mRNA be required?
Although many questions remain, signiﬁcant
progress has been made into understanding the inter-
actions involved between VcHfq and the Qrr sRNAs.
Furthermore, our novel approach for modelling SAS
data of complexes in which at least one component does
not change structure should allow similar studies to be
completed for other Hfq-RNA complexes.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Table 1 and Supplementary Figures 1–6.
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